MR-191-N

N/A

Report date: 2025/06/11 10:58:34

Base Information

Drug NameMR-191-N
Drug Alias Nameanti-Marburg virus mAbs (Mapp biopharmaceutical/USAMRIID)anti-Marburg virus monoclonal antibodies (Mapp biopharmaceutical/US Army Medical Research Institute of Infectious Diseases)MR-191-NMR-191
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMarburg Virus Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMapp Biopharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesMapp Biopharmaceutical IncUS Army Medical Research Institute of Infectious Diseases
Inactive CompaniesN/A
Active IndicationsMarburg Virus Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A